HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a new bladder cancer strategy spare patients a second surgery?
Disease control Recruiting nowThis study is testing if a new approach can safely reduce the need for a second surgery in people with non-muscle invasive bladder cancer. The new method uses special MRI scans and a dye that makes tumors glow under blue light during the first surgery to help remove them more com…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New vaccine aims to train immune system to fight tough bladder cancer
Disease control Recruiting nowThis early-stage study is testing whether a new vaccine (IO102-IO103) combined with an existing immunotherapy drug (pembrolizumab) is safe and effective for patients with high-risk bladder cancer that hasn't responded to standard BCG treatment. The vaccine is designed to teach th…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC